Aptevo Therapeutics Inc (APVO)
0.6812
-0.06
(-7.47%)
USD |
NASDAQ |
Apr 24, 16:00
0.6812
0.00 (0.00%)
After-Hours: 20:00
Aptevo Therapeutics Total Liabilities (Quarterly): 12.62M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.62M |
| September 30, 2023 | 12.41M |
| June 30, 2023 | 12.66M |
| March 31, 2023 | 11.71M |
| December 31, 2022 | 16.24M |
| September 30, 2022 | 15.93M |
| June 30, 2022 | 15.75M |
| March 31, 2022 | 51.07M |
| December 31, 2021 | 55.38M |
| September 30, 2021 | 56.71M |
| June 30, 2021 | 57.59M |
| March 31, 2021 | 58.25M |
| December 31, 2020 | 36.95M |
| September 30, 2020 | 35.22M |
| June 30, 2020 | 9.859M |
| March 31, 2020 | 10.09M |
| December 31, 2019 | 41.57M |
| Date | Value |
|---|---|
| September 30, 2019 | 40.81M |
| June 30, 2019 | 39.93M |
| March 31, 2019 | 41.71M |
| December 31, 2018 | 37.09M |
| September 30, 2018 | 34.93M |
| June 30, 2018 | 33.97M |
| March 31, 2018 | 31.85M |
| December 31, 2017 | 34.97M |
| September 30, 2017 | 40.71M |
| June 30, 2017 | 35.47M |
| March 31, 2017 | 36.31M |
| December 31, 2016 | 41.29M |
| September 30, 2016 | 36.87M |
| June 30, 2016 | 20.96M |
| March 31, 2016 | 22.74M |
| December 31, 2015 | 39.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.859M
Minimum
Jun 2020
58.25M
Maximum
Mar 2021
31.09M
Average
35.22M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Heron Therapeutics Inc | 256.48M |
| Creative Medical Technology Holdings Inc | 0.3714M |
| BioSig Technologies Inc | 4.685M |
| Adial Pharmaceuticals Inc | 0.6531M |
| IN8bio Inc | 8.772M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.84M |
| Shareholders Equity (Quarterly) | 12.22M |